Stopping the Cure:
Why Cancer Research isn’t Focused On the True Cause of Cancer
By Tony Isaacs
Since the war on cancer was declared half a century ago, hundreds of billions of dollars have been poured into cancer research. However, despite annual pronouncements of cures and breakthroughs that are just around the corner, all that research has failed to keep the incidence of cancer from continuing to increase. Most of the small reductions in cancer deaths are due mostly to earlier detection which increases five year survival rates – the yardstick conventional medicine uses to determine success.
There is a very good explanation for why cancer research has failed so badly…
It has been directed away from the true main cause of most cancer – toxins. In early years, such misdirection could be partially explained by the lack of understanding about the nature and causes of cancer. In recent decades, however, cancer research has been directed away from toxins even as the evidence has mounted that toxins are indeed the primary cause of cancer. The reasons for misdirecting cancer research are two-fold:
- Covering up the culpability of those who produce toxins and sell toxic products
- Greed on the part of mainstream medicine and others who profit from cancer
As an example of the way cancer causes are covered up and the greed that drives the cancer industry, consider the marketing of “pink.” Many of the companies who are part of the hugely publicized Breast Cancer Awareness Movement (BCAM) sell pink-themed products which contain cancer causing toxins.
The Great Pink “Cancer Cover-Up”
There has been a huge effort for many decades to direct attention away from toxins. If toxins were